Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial

Triaging HPV-positive women with p16/Ki-67 dual-stained cytology: Results from a sub-study nested into the ATHENA trial

(2017) Thomas C. Wright et al.   GYNECOLOGIC ONCOLOGY

Transitioning from cytology-based screening to HPV-based screening at longer intervals: implications for resource use

(2016) Megan A. Smith et al.   BMC HEALTH SERVICES RESEARCH

HPV for cervical cancer screening (HPV FOCAL): Complete Round 1 results of a randomized trial comparing HPV-based primary screening to liquid-based cytology for cervical cancer

(2016) Gina S. Ogilvie et al.   INTERNATIONAL JOURNAL OF CANCER

Human papillomavirus testing versus cytology in primary cervical cancer screening: End-of-study and extended follow-up results from the Canadian cervical cancer screening trial

(2016) Sandra D. Isidean et al.   INTERNATIONAL JOURNAL OF CANCER

HPV vaccine impact in Australian women: ready for an HPV-based screening program

(2016) Julia ML Brotherton et al.   MEDICAL JOURNAL OF AUSTRALIA

Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test

(2015) Thomas C. Wright et al.   GYNECOLOGIC ONCOLOGY

Fall in Genital Warts Diagnoses in the General and Indigenous Australian Population Following Implementation of a National Human Papillomavirus Vaccination Program: Analysis of Routinely Collected National Hospital Data

(2014) Megan A. Smith et al.   JOURNAL OF INFECTIOUS DISEASES

Reassurance Against Future Risk of Precancer and Cancer Conferred by a Negative Human Papillomavirus Test

(2014) J. C. Gage et al.   JNCI-Journal of the National Cancer Institute

Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial

(2014) K. M. Elfstrom et al.   BMJ-British Medical Journal

Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

(2013) Guglielmo Ronco et al.   LANCET

Human papillomavirus vaccine coverage among female Australian adolescents: success of the school-based approach

(2013) Julia M L Brotherton et al.   MEDICAL JOURNAL OF AUSTRALIA

Human papillomavirus (HPV) vaccination coverage in young Australian women is higher than previously estimated: Independent estimates from a nationally representative mobile phone survey

(2013) Julia M.L. Brotherton et al.   VACCINE

Fall in Human Papillomavirus Prevalence Following a National Vaccination Program

(2012) S. N. Tabrizi et al.   JOURNAL OF INFECTIOUS DISEASES

Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer

(2012) Marc Arbyn et al.   VACCINE

The ATHENA human papillomavirus study: design, methods, and baseline results

(2011) Thomas C. Wright et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination program

(2011) Suzanne M Garland et al.   BMC Medicine

A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: Extended follow up in the ARTISTIC trial

(2011) Henry C. Kitchener et al.   EUROPEAN JOURNAL OF CANCER

Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial

(2011) Dorien C Rijkaart et al.   LANCET ONCOLOGY

Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial

(2010) Guglielmo Ronco et al.   LANCET ONCOLOGY